Biogen
BIIB
BIIB
1,013 hedge funds and large institutions have $59B invested in Biogen in 2017 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 380 increasing their positions, 355 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,013
Holders Change
+22
Holders Change %
+2.22%
% of All Funds
25.29%
Holding in Top 10
38
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+65.22%
% of All Funds
0.95%
New
99
Increased
380
Reduced
355
Closed
68
Calls
$974M
Puts
$1.24B
Net Calls
-$269M
Net Calls Change
-$87M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$543M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$328M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$188M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$177M |
| 5 |
Bank of New York Mellon
New York
|
+$141M |
Top Sellers
| 1 |
BlackRock
New York
|
-$364M |
| 2 |
D.E. Shaw & Co
New York
|
-$218M |
| 3 |
Renaissance Technologies
New York
|
-$201M |
| 4 |
SIG
Senator Investment Group
New York
|
-$136M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$126M |